Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Researchers show hormone offers hope as a new fertility treatment

06.03.2007
A group of scientists at Hammersmith Hospital, Imperial College London, have shown for the first time that giving women the hormone kisspeptin stimulates release of the sex hormones which control periods. This finding suggests that kisspeptin could be a potential new treatment for fertility.

Kisspeptin is a hormone coded by the KiSS-1 gene. This gene was discovered in Hershey, Pennsylvania, and researchers decided to name it after the town’s most famous product, the Hershey chocolate “Kiss”. Animals and humans lacking kisspeptin function do not go through puberty and remain sexually immature.

The scientists at Imperial College injected a small group of healthy female volunteers with the hormone kisspeptin. Soon after injection the volunteers showed a rise in their circulating concentrations of luteinising hormone (LH), a hormone which can be used to stimulate the ovary in fertility treatment.

Kisspeptin increased LH concentrations at all stages of the menstrual cycle, but the effect was greatest in the pre ovulation phase, which is essential for fertility. This is the first time that kisspeptin has been shown to have a stimulatory effect on LH in women.

... more about:
»Kisspeptin »fertility »hormone »stimulate

It’s likely that the next steps will be to test the effects of kisspeptin in patients with disorders of sexual regulation.

Researcher Dr Waljit Dhillo said:

‘Kisspeptin has previously been shown to potently stimulate hormone release in animals, but this is the first time that it has been shown to stimulate sex hormone release in women. Kisspeptin is a promising new tool for the restoration of normal reproductive function in women with low sex hormone levels’.

Jo Thurston | alfa
Further information:
http://www.endocrinology.org
http://www.endocrine-abstracts.org/ea/0013/ea0013oc17.htm

Further reports about: Kisspeptin fertility hormone stimulate

More articles from Life Sciences:

nachricht One step closer to reality
20.04.2018 | Max-Planck-Institut für Entwicklungsbiologie

nachricht The dark side of cichlid fish: from cannibal to caregiver
20.04.2018 | Veterinärmedizinische Universität Wien

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Spider silk key to new bone-fixing composite

University of Connecticut researchers have created a biodegradable composite made of silk fibers that can be used to repair broken load-bearing bones without the complications sometimes presented by other materials.

Repairing major load-bearing bones such as those in the leg can be a long and uncomfortable process.

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Magnetic nano-imaging on a table top

20.04.2018 | Physics and Astronomy

Start of work for the world's largest electric truck

20.04.2018 | Interdisciplinary Research

Atoms may hum a tune from grand cosmic symphony

20.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>